Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ · Healthcare
Insight Molecular Diagnostics Inc. Cash on Hand 2020–2025
Insight Molecular Diagnostics Inc. annual/quarterly cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Insight Molecular Diagnostics Inc. cash on hand for the quarter ending December 31, 2025 were 11.6M, a 34.12% increase year-over-year.
- Insight Molecular Diagnostics Inc. cash on hand for 2025 were 11.6M, a 34.12% increase from 2024.
- Insight Molecular Diagnostics Inc. cash on hand for 2024 were 8.6M, a 8.44% decrease from 2023.
- Insight Molecular Diagnostics Inc. cash on hand for 2023 were 9.4M, a 52.82% decrease from 2022.
- Insight Molecular Diagnostics Inc. cash on hand for 2022 were 20.0M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Insight Molecular Diagnostics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $12 |
| 2024 | $9 |
| 2023 | $9 |
| 2022 | $20 |
| 2021 | $33 |
| 2020 | $7 |
| Insight Molecular Diagnostics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $12 |
| 2024-12-31 | $9 |
| 2023-12-31 | $9 |
| 2022-12-31 | $20 |
| 2021-12-31 | $33 |
| 2020-12-31 | $7 |
Insight Molecular Diagnostics Inc. Cash on Hand — FAQ
Insight Molecular Diagnostics Inc. (IMDX) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMDX's cash on hand history?
The chart and table above show Insight Molecular Diagnostics Inc.'s cash on hand by year and by quarter, including the growth rate.